SEC
Filing

SEC Filing Details

Document Details

Filing Date
Oct 19, 2017
Document Date
Oct 19, 2017
Form Description
An amendment to a SC 13D filing
Filing Group
Other
Company
Altimmune
Issuer
ALTIMMUNE, INC.
 

Investor Contact

Richard Eisenstadt
Chief Financial Officer

Email: reisenstadt@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe